Nuage Therapeutics

Nuage Therapeutics

Develops new selective and potent drugs for intrinsically disordered targets.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
*

€1.8m

Valuation: €60.0m

Early VC
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads